Analyst picks & changes

Ligand Pharmaceuticals Inc.

(LGND)

Molowa of Bear Stearns began coverage with an "attractive" rating. He said the stock is undervalued

Read the full 207 word article

How to gain access

Continue reading with a
two-week free trial.